3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy

3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy

Therapy for Parkinson’s disease is quite challenging. Numerous drugs are available for symptomatic treatment, and levodopa (LD), in combination with a dopa decarboxylase inhibitor (e.g., benserazide (BZ)), has been the drug of choice for years. As the disease progresses, therapy must be supplemented...

Full description

Bibliographic Details
Main Authors: Hellen Windolf, Rebecca Chamberlain, Jörg Breitkreutz, Julian Quodbach
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pharmaceutics
Subjects:
FDM 3D printing
polypill
Morbus Parkinson
personalized medicine
additive manufacturing
gastro retentive drug delivery
Online Access:https://www.mdpi.com/1999-4923/14/5/931

Similar Items

Similar Items